School of Medicine
Showing 1,731-1,740 of 5,029 Results
-
Sean Edmund Harris, MB BCh BAO
Clinical Assistant Professor, Surgery - Vascular Surgery
BioDr. Sean Edmund Harris is a board-eligible vascular surgeon with Stanford Health Care Vascular and Endovascular Care. He is also an assistant professor in the Department of Surgery, Division of Vascular Surgery at Stanford University School of Medicine.
Dr. Harris specializes in creating and maintaining dialysis access, working closely with nephrologists to provide complex kidney disease care. His other interests include venous disease management and endovascular management of aortic and peripheral vascular diseases. As a physician-researcher, Dr. Harris has traveled around the world and brings extensive and diverse vascular education back to his patients. He also understands the needs of the local community as a San Francisco Bay Area native.
Dr. Harris has published his findings in several peer-reviewed journals, including Annals of Vascular Surgery, the Journal of the American College of Surgeons, the Journal of Vascular Surgery, and the Journal of Thoracic and Cardiovascular Surgery. He has also shared his expertise globally, presenting leading-edge vascular surgery research at prominent conferences of the Society for Vascular Surgery (SVS), the European Society for Vascular Surgery, and the International Aortic Summit.
Dr. Harris is a member of the New England Society for Vascular Surgery and the SVS. -
Geoffrey Hart-Cooper
Clinical Associate Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsDr. Hart-Cooper's research focuses on youth provider barriers and education surrounding pre-exposure prophylaxis for HIV (PrEP). He founded the Virtual PrEP Program for Adolescents and Young Adults at Stanford to improve access to PrEP care for youth within California. In his current role, he advises health departments and health systems in creating youth-focused telehealth tools to improve youth access to PrEP.
-
Phillip M. Harter, M.D.
Associate Professor (Teaching) of Emergency Medicine, Emeritus
Current Research and Scholarly InterestsMedical Education, particularly the role of simulation (part-task trainers, human patient simulators and virtual reality) in the education of medical students and residents. Also, the use of the internet for distance learning in health care professions.
-
Gary E Hartman, MD, MBA
Clinical Professor, Surgery - Pediatric Surgery
Affiliate, Surgery - Pediatric SurgeryCurrent Research and Scholarly InterestsMinimal Access and Robotic Surgery
Neonatal Surgery
Childhood Oncology -
Mary Elizabeth Hartnett, MD
Michael F. Marmor, M.D. Professor of Retinal Science and Disease and Professor of Ophthalmology
BioMary Elizabeth Hartnett, MD, is the Michael F. Marmor, M.D. Professor in Retinal Science and Diseases and is a Professor of Ophthalmology at Stanford University. Dr. Hartnett is the director of Pediatric Retina at Stanford University and principal investigator of a retinal angiogenesis laboratory, in which she studies causes and treatments for diseases including retinopathy of prematurity and age-related macular degeneration. She created the first-ever academic textbook on the subject, Pediatric Retina, in its third edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally.
Dr. Hartnett’s NIH-funded laboratory of vascular biology and angiogenesis has studied mechanisms causing pathology in age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). Her work in AMD has been to understand the mechanisms involved in activation and invasion of choroidal endothelial cells anterior to the RPE in order to maintain vasculature that is physiologic and not damaging beneath the RPE. Her lab has elucidated environmental stressors that lead to scarring in the macula for which no vision improvement is currently possible. The goal is to find methods to prevent the scarring.
Her lab’s work in ROP provided the proof of concept to regulate an angiogenic signaling pathway by inhibiting VEGF to facilitate intraretinal neovascularization as well as to inhibit abnormal extraretinal neovascularization and reduce retinal destruction used in previous treatments. Her work has been translated through clinical trials to lead to new treatments for severe ROP and has represented a paradigm shift in the understanding and treatment of severe ROP.
Dr. Hartnett has received numerous awards, including the Weisenfeld Award, the highest award for clinician-scientists given by the Association for Research in Vision and Ophthalmology (ARVO), in 2018, and is an ARVO Gold Fellow. She received the 2019 Paul Kayser/Retina Research Foundation Global Award, the Macula Society’s 2016 Paul Henkind Award and its 2019 Arnall Patz Medal, the Paul Kayser/RRF Global Award from the PanAmerica Society, and the 2021 Suzanne Veronneau-Troutman Award, the most prestigious award from Women in Ophthalmology. In 2022, she was one of six at the University of Utah to receive a distinguished research award, for Pediatrics and Ophthalmology. In recognition of her lifetime contributions, she was inducted into the Retina Hall of Fame and was elected to the Association of American Physicians in 2025.
Dr. Hartnett's prolific publication record includes 295 articles in peer-reviewed journals and over 40 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, as a mentor for the ARVO Leadership Development Program, and in leadership positions internationally as the Treasurer for The Macula Society and the Chair of the Jack McGovern Coats Disease Foundation as well as the Credentialing Committee for The Retina Society. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the American Journal of Ophthalmology. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of the Association for Research in Vision and Ophthalmology (FARVO). -
Stella Hartono
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioStella Hartono, MD PhD is a board-certified allergy/immunology physician and clinical researcher. She specializes in diagnosing and treating immunology and allergic conditions, with a focus on immunodeficiency, immune dysregulation, hyper eosinophilia, and pet allergies.
Dr. Hartono’s clinical research focuses on the role of age-associated B cells in vaccine response and the aging immune system. She is also interested in improving diagnosis and treatment options for patients with CVID (common variable immunodeficiency) and SAD (specific antibody deficiency). She has published her original research in peer-reviewed scientific journals and presented at national conferences, including annual meetings for the Clinical Immunology Society and the American Academy of Asthma, Allergy, and Immunology, as well as international conferences, including annual meeting for the European Academy of Allergy and Clinical Immunology. Dr. Hartono is a member of the American Academy of Asthma, Allergy, and Immunology, the Clinical Immunology Society, and the American College of Allergy, Asthma, and Immunology.
